1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd
  6. News
  7. Summary
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD

(4519)
  Report
Delayed Japan Exchange  -  05/20 02:00:00 am EDT
3536.00 JPY   +0.31%
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
AQ
04/27CHUGAI PHARMACEUTICAL : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Launch of Chugai's New TV Commercial 'Protect the Ordinary Days People Cherish' Featuring Kento Nagayama as a Researcher in 'Chugai Innovation Lab'

12/24/2021 | 03:50am EDT

TOKYO - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it has launched a new TV commercial series called 'Protect the Ordinary Days People Cherish.'

Under its business philosophy of 'Innovations all for the patients,' Chugai aims to add exceptional value through the creation of innovative medical products and services for the benefit of the medical community and human health around the world.

The setting for the commercial is an imaginary laboratory called 'Chugai Innovation Lab,' where scenes from around the world are projected on different monitors. The actor Kento Nagayama, who plays the role of a researcher, and the robot 'ChuLabo' are watching one monitor that shows a father and child on Sports Day. The researcher and robot ask themselves why they are pursuing innovation, and by watching the monitors, they realize their mission is to create new drugs to protect the ordinary days of people.

The new commercial expresses our stance and the hope of Chugai employees to meet the expectations of patients around the world who are waiting for effective treatments. We will do that by pursuing continuous innovation and contributing to their health and happiness. Chugai is advancing its growth strategy 'TOP I 2030' with the aim of becoming a top innovator in the healthcare industry in 2030. We will continue to enhance awareness and understanding through branding activities and to build trust with our stakeholders.

The rollout of the new corporate advertisement on TV commercial starts today and will be placed on the internet and SNS in Japan.

URL: https://youtu.be/r0fCf4OqIZ8 (Japanese Only)

About the cast: Kento Nagayama

Actor. Born in Tokyo on March 7,1989. In July 2007, made his drama debut in the NTV drama series 'Ojiisan Sensei'. Since then, he has appeared in a variety of films, including NHK's serial television series 'Beppin-san,' the historical drama 'Idaten,' the movie 'Fuganai Boku wa Sora wo Mita,' and 'Life and Death by on the Shore'. He will appear in TV Tokyo New Year Drama Special 'Yasahii Ongaku' and the movie 'Toge Last Samurai' to be released in 2022.

Contact:

Media

Chugai Pharmaceutical Co., Ltd.

Media Relations Group

Corporate Communications Dept.

Tomoko Shimizu

Tel: +81-3-3273-0881

E-mail: pr@chugai-pharm.co.jp

Investors

Chugai Pharmaceutical Co., Ltd.

Investor Relations Group

Corporate Communications Dept.

Toshiya Sasai

Tel: +81-3-3273-0554

E-mail: ir@chugai-pharm.co.jp

(C) 2021 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
CHUGAI PHARMACEUTICAL CO., LTD 0.31% 3536 Delayed Quote.-5.33%
ROCHE HOLDING AG 0.88% 319.7 Delayed Quote.-15.67%
All news about CHUGAI PHARMACEUTICAL CO., LTD
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares a..
AQ
04/27CHUGAI PHARMACEUTICAL : Notice of Completion of Disposal of Treasury Shares as Restricted ..
PU
04/26CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
04/26Chugai Pharmaceutical Co., Ltd. - Organizational and Personnel Changes
AQ
04/26Nikkei 225 Up 0.4% on Wall Street Cues, Softer Interest Rates, Oil Outlook
MT
04/26Chugai Pharmaceutical Logs 178% Surge in Q1 Net Income on Higher Sales
MT
04/25CHUGAI PHARMACEUTICAL : 1Q Results (Jan-Mar 2022)
PU
04/25Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces First Quarter Sales 20..
AQ
04/25CHUGAI PHARMACEUTICAL : Supplementary Materials for Consolidated Financial Results for the..
PU
More news
Analyst Recommendations on CHUGAI PHARMACEUTICAL CO., LTD
More recommendations
Financials
Sales 2022 1 187 B 9 282 M 9 282 M
Net income 2022 343 B 2 679 M 2 679 M
Net cash 2022 604 B 4 723 M 4 723 M
P/E ratio 2022 17,0x
Yield 2022 2,20%
Capitalization 5 815 B 45 478 M 45 478 M
EV / Sales 2022 4,39x
EV / Sales 2023 4,88x
Nbr of Employees 7 664
Free-Float 37,8%
Chart CHUGAI PHARMACEUTICAL CO., LTD
Duration : Period :
Chugai Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 3 536,00 JPY
Average target price 4 677,69 JPY
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
Tatsuro Kosaka Manager-Pharmaceutical Business Strategy Office
Osamu Okuda Manager-Life Cycle Management II
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Junichi Nezu Executive Officer, GM-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CHUGAI PHARMACEUTICAL CO., LTD-5.33%45 478
JOHNSON & JOHNSON1.68%465 705
PFIZER, INC.-11.14%294 404
ELI LILLY AND COMPANY8.19%269 013
ABBVIE INC.11.53%266 851
ROCHE HOLDING AG-15.67%266 707